US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

PGEN

Precigen (PGEN)

Precigen Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PGEN

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/09	05 : 05	PR Newswire (US)	Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual Meeting	NASDAQ:PGEN	Precigen Inc
2024/04/24	23 : 20	PR Newswire (US)	Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting	NASDAQ:PGEN	Precigen Inc
2024/04/24	22 : 00	PR Newswire (US)	Actym Therapeutics Appoints Thomas Smart as CEO	NASDAQ:PGEN	Precigen Inc
2024/03/29	05 : 05	PR Newswire (US)	Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th	NASDAQ:PGEN	Precigen Inc
2024/03/20	05 : 05	PR Newswire (US)	Precigen Reports Full Year 2023 Financial Results and Business Updates	NASDAQ:PGEN	Precigen Inc
2024/03/19	20 : 27	IH Market News	US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat	NASDAQ:PGEN	Precigen Inc
2024/03/13	05 : 05	PR Newswire (US)	Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis	NASDAQ:PGEN	Precigen Inc
2024/03/06	06 : 05	PR Newswire (US)	Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th	NASDAQ:PGEN	Precigen Inc
2024/02/28	03 : 48	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PGEN	Precigen Inc
2024/02/15	06 : 00	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:PGEN	Precigen Inc
2024/02/15	05 : 20	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PGEN	Precigen Inc
2024/02/09	06 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PGEN	Precigen Inc
2024/02/07	06 : 05	PR Newswire (US)	Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:PGEN	Precigen Inc
2024/01/18	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PGEN	Precigen Inc
2024/01/16	22 : 05	PR Newswire (US)	Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission	NASDAQ:PGEN	Precigen Inc
2024/01/08	22 : 39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PGEN	Precigen Inc
2024/01/08	22 : 30	PR Newswire (US)	Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:PGEN	Precigen Inc
2023/12/30	07 : 26	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PGEN	Precigen Inc
2023/12/19	06 : 05	PR Newswire (US)	Precigen to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:PGEN	Precigen Inc
2023/11/30	06 : 05	PR Newswire (US)	Precigen to Participate in the JMP Securities Hematology and Oncology Summit	NASDAQ:PGEN	Precigen Inc
2023/11/10	07 : 08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PGEN	Precigen Inc
2023/11/10	07 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PGEN	Precigen Inc
2023/11/10	06 : 55	PR Newswire (US)	Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs	NASDAQ:PGEN	Precigen Inc
2023/11/08	06 : 05	PR Newswire (US)	Precigen to Participate in the Stifel 2023 Healthcare Conference	NASDAQ:PGEN	Precigen Inc
2023/09/20	05 : 05	PR Newswire (US)	Precigen to Participate in Upcoming Leading Investor and Industry Conferences	NASDAQ:PGEN	Precigen Inc
2023/08/26	08 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PGEN	Precigen Inc
2023/08/26	08 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PGEN	Precigen Inc
2023/08/26	08 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PGEN	Precigen Inc
2023/08/26	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PGEN	Precigen Inc
2023/08/26	07 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PGEN	Precigen Inc

Showing the most relevant articles for your search:NASDAQ:PGEN

1 2 3 4 5 6 7 8 9 10 次へ >>

Energy Select Sector SPDR

American Express

JP Morgan Chase

Verizon Communications

US Dollar vs Euro

US Dollar vs Yen

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約